Target Price | $52.53 |
Price | $36.99 |
Potential |
42.01%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target AtriCure, Inc. 2026 .
The average AtriCure, Inc. target price is $52.53.
This is
42.01%
register free of charge
$63.00
70.32%
register free of charge
$40.40
9.22%
register free of charge
|
|
A rating was issued by 15 analysts: 14 Analysts recommend AtriCure, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the AtriCure, Inc. stock has an average upside potential 2026 of
42.01%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 465.31 | 541.26 |
16.55% | 16.32% | |
EBITDA Margin | -7.95% | 9.55% |
33.75% | 220.13% | |
Net Margin | -9.61% | -4.13% |
26.00% | 57.01% |
11 Analysts have issued a sales forecast AtriCure, Inc. 2025 . The average AtriCure, Inc. sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an AtriCure, Inc. EBITDA forecast 2025. The average AtriCure, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 AtriCure, Inc. Analysts have issued a net profit forecast 2025. The average AtriCure, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.95 | -0.45 |
43.94% | 52.63% | |
P/E | negative | |
EV/Sales | 3.31 |
11 Analysts have issued a AtriCure, Inc. forecast for earnings per share. The average AtriCure, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Needham |
Locked
➜
Locked
|
Locked | Jul 30 2025 |
UBS |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
Needham |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Mar 27 2025 |
Analyst Rating | Date |
---|---|
Locked
Needham:
Locked
➜
Locked
|
Jul 30 2025 |
Locked
UBS:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
Needham:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Apr 02 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 28 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Mar 27 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.